ELK3 and adenocarcinoma: In the prostate cancer DU145 cell line, also generated from adenocarcinoma, it has been reported that the upregulation of SERPINE1 (a serine protease inhibitor) diminishes cell proliferation and this effect is induced via activation of the AKT pathway after silencing the transcription factor ELK3 [23].